# A Safety and Efficacy Study Comparing Fibrocaps and Tachosil in Hepatic Surgery

> **NCT02284256** · PHASE3 · COMPLETED · sponsor: **Mallinckrodt** · enrollment: 150 (actual)

## Conditions studied

- Surgical Bleeding

## Interventions

- **DRUG:** Fibrocaps
- **DRUG:** TachoSil

## Key facts

- **NCT ID:** NCT02284256
- **Lead sponsor:** Mallinckrodt
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2015-08
- **Final completion:** 2015-08
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2017-08-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02284256

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02284256, "A Safety and Efficacy Study Comparing Fibrocaps and Tachosil in Hepatic Surgery". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT02284256. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*